From 1 November 2023, the list of medicines covered by the HRT prepayment certificate (HRT PPC) will be updated to include a new brand of progesterone micronised capsules, Gepretix®.
Part XVI of the November 2023 Drug Tariff will be updated to include the following new HRT medicine for which patients will be able to purchase an HRT PPC:
Gepretix® – Progesterone micronised 100mg capsules
In June 2023, we announced the addition of the following medicines to the HRT PPC list.
Tibolone 2.5mg tablets (Livial®)
Prasterone 6.5mg pessaries (Intrarosa®)
Pharmacy teams should also note that the following HRT three medicines have been discontinued and will be removed from the list of medicines covered by the HRT PPC in August 2024:
Bedol® 2mg tablets
Climanor® 5mg tablets
Pharmacy staff are advised to check the NHSBSA website for an up-to-date list of HRT medicines covered by the HRT PPC. Community Pharmacy England (formerly PSNC) has updated its HRT medicines list to reflect the changes taking effect from November 2023. Please note: you may need to hard refresh (press Ctrl+R) to refer to the most up-to-date version.
The HRT medicines list has been compiled following consultation with the Medicines and Healthcare products Regulatory Agency (MHRA), NHSBSA and the NHS England Menopause Clinical Reference Group. The list will be updated as new HRT medicines licensed for the treatment of menopause become available in the UK or as existing HRT medicines are discontinued from the UK market. If a product that meets the criteria is missing from the HRT medicines list please contact email@example.com.
The post Gepretix® added to the HRT PPC medicines list from November 2023 appeared first on Community Pharmacy England.